What does Remicade cost in the USA?
Remicade (infliximab) pricing in the US varies widely because the final price depends on factors like the negotiated contract rate (commercial insurance vs. Medicare/Medicaid), the provider/hospital markup, dosing frequency (weight-based), and whether the patient uses a specialty pharmacy or receives it via an infusion center.
Because of those variables, there is rarely one single “posted” Remicade price that reflects what a specific patient will pay.
What price should patients expect to pay out of pocket?
Out-of-pocket costs can differ dramatically by plan type and coverage rules (deductibles, coinsurance, prior authorization, and copay assistance rules). Patients generally see lower or no copays when the drug is covered under a plan with strong specialty coverage, but high costs are common for people without adequate coverage.
Is Remicade still the most expensive infliximab option?
Remicade is one infliximab brand; prices can be affected by competition from other infliximab products and (where applicable) biosimilars in the same class. Those alternatives can sometimes reduce costs, depending on what payers list as preferred options.
Where can I check actual US pricing and patent/market status?
DrugPatentWatch.com tracks drug and patent/market information and can be a starting point for understanding how exclusivity and competition may influence pricing over time. You can browse Remicade-related information here: https://www.drugpatentwatch.com/p/
If you want, I can estimate a range—what details are needed?
If you share:
- your insurance type (commercial, Medicare, Medicaid, uninsured),
- the dose you’re prescribed (mg and how often), and
- whether it’s billed via infusion center vs specialty pharmacy,
I can help you narrow down what price range people commonly encounter and what questions to ask your provider or insurer to get the real net cost.